| #41 |
Lorena Lerner |
Aveo Pharmaceuticals |
3 |
| #41 |
Ana L. Lattes |
E Ink Holdings |
3 |
| #41 |
Colin Whittaker |
Amazon |
3 |
| #41 |
Seth S. Kessler |
Metis Design |
3 |
| #41 |
Dedong Wu |
Astrazeneca Ab |
3 |
| #41 |
Omri Kessel |
Netapp |
3 |
| #41 |
Stuart E. Schechter |
Monotony.Ai |
3 |
| #41 |
Kim Lewis |
Novobiotic Pharmaceuticals |
3 |
| #41 |
Michael Aaron Brodney |
Pfizer |
3 |
| #41 |
Chase Spenser Coffman |
Elektrofi |
3 |
| #61 |
Roman Lvovitch Bogorad |
Crispr Therapeutics Ag |
2 |
| #61 |
Gilad Jacobs |
Hyperice Ip Subco |
2 |
| #61 |
Jack J. Schuss |
RTX (Raytheon) |
2 |
| #61 |
Naizhong Chiu |
Emc Ip Holding Company |
2 |
| #61 |
Nikolaos Papaioannou |
Pfizer |
2 |
| #61 |
Jungwook Yang |
IBM |
2 |
| #61 |
Brett Isenberg |
Draper Laboratory |
2 |
| #61 |
Nikolay V. Vasilyev |
Children'S Medical Center |
2 |
| #61 |
Jie He |
Foundation Medicine |
2 |
| #61 |
Shitong S. Zhu |
Saudi Arabian Oil |
2 |
| #61 |
Ehimwenma NOSAKHARE |
Microsoft |
2 |
| #61 |
Lidia Mosyak |
Pfizer |
2 |
| #61 |
Semyon Kogan |
— |
2 |
| #61 |
Matthew J. Hawryluk |
Foundation Medicine |
2 |
| #61 |
Gurkan Guntas |
Pfizer |
2 |
| #61 |
Brian T. Hopkins |
Biogen Ma |
2 |
| #61 |
Kenneth T. Kotz |
The General Hospital |
2 |
| #61 |
Joseph F. Arboleda-Velasquez |
Schepens Eye Research Institute |
2 |
| #61 |
Deepak Ramaswamy |
Xanavi Informatics |
2 |
| #61 |
Brian Bean |
E Ink Holdings |
2 |
| #61 |
Gerard M. Reilly |
Isolynx |
2 |
| #61 |
Matthew C. Ebbs |
Rai Strategic Holdings |
2 |
| #61 |
Charles A. Lesburg |
Merck |
2 |
| #61 |
Carrie Marie Margulies |
Editas Medicine |
2 |
| #61 |
David J. Michael |
Cognex |
2 |
| #61 |
Sharon Shacham |
Karyopharm Therapeutics |
2 |
| #61 |
Fernando G. Vieira |
Als Therapy Development Institute |
2 |
| #61 |
Samuel Ross Madden |
Cambridge Mobile Telematics |
2 |
| #61 |
Jeffrey R. Jasperse |
Siemens Healthcare Diagnostics |
2 |
| #61 |
Bernard Ravina |
Voyager Therapeutics |
2 |
| #61 |
Doron Levari |
Ignite Scalarc Solutions |
2 |
| #61 |
Alexander Kesler |
Fortifyiq |
2 |
| #61 |
Brice Dubost |
Certainteed |
2 |
| #61 |
Leonardus H. T. Van Der Ploeg |
Merck |
2 |
| #61 |
Harvey Cohen |
Fresenius Medical Care Holdings |
2 |
| #61 |
Andrew D. Levin |
Imbria Pharmaceuticals |
2 |
| #61 |
Jay Rodney Walton |
Qualcomm |
2 |
| #61 |
Roman Yelensky |
Foundation Medicine |
2 |
| #61 |
Thomas A. Cerruti |
Monsanto Technology |
2 |
| #61 |
Antonio Varone |
Emulate |
2 |